Global Biosimilars and Follow-on Biologic Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Biosimilars and Follow-on Biologic market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Biosimilars and Follow-on Biologic market are covered in Chapter 9:
Mitsubishi Tanabe Pharma Corporation
Bristol-Myers Squibb
CCL Pharmaceuticals
Amphastar Pharmaceuticals
Biogen Idec
Abbott
3SBio
Abraxis BioScience
Zenotech
GlaxoSmithKline (GSK)
Sandoz
Johnson & Johnson
Alexion Pharmaceuticals,
Ranbaxy Laboratories
Genentech
Dr. Reddy’s Laboratories
In Chapter 5 and Chapter 7.3, based on types, the Biosimilars and Follow-on Biologic market from 2017 to 2027 is primarily split into:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
In Chapter 6 and Chapter 7.4, based on applications, the Biosimilars and Follow-on Biologic market from 2017 to 2027 covers:
Blood Disorders
Oncology Diseases
Chronic & Autoimmune Diseases
Growth Hormone Deficiencies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Biosimilars and Follow-on Biologic market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Biosimilars and Follow-on Biologic Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Biosimilars and Follow-on Biologic market are covered in Chapter 9:
Mitsubishi Tanabe Pharma Corporation
Bristol-Myers Squibb
CCL Pharmaceuticals
Amphastar Pharmaceuticals
Biogen Idec
Abbott
3SBio
Abraxis BioScience
Zenotech
GlaxoSmithKline (GSK)
Sandoz
Johnson & Johnson
Alexion Pharmaceuticals,
Ranbaxy Laboratories
Genentech
Dr. Reddy’s Laboratories
In Chapter 5 and Chapter 7.3, based on types, the Biosimilars and Follow-on Biologic market from 2017 to 2027 is primarily split into:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
In Chapter 6 and Chapter 7.4, based on applications, the Biosimilars and Follow-on Biologic market from 2017 to 2027 covers:
Blood Disorders
Oncology Diseases
Chronic & Autoimmune Diseases
Growth Hormone Deficiencies
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Biosimilars and Follow-on Biologic market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Biosimilars and Follow-on Biologic Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilars and Follow-on Biologic Market
1.2 Biosimilars and Follow-on Biologic Market Segment by Type
1.2.1 Global Biosimilars and Follow-on Biologic Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biosimilars and Follow-on Biologic Market Segment by Application
1.3.1 Biosimilars and Follow-on Biologic Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biosimilars and Follow-on Biologic Market, Region Wise (2017-2027)
1.4.1 Global Biosimilars and Follow-on Biologic Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.3 Europe Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.4 China Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.5 Japan Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.6 India Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.8 Latin America Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biosimilars and Follow-on Biologic (2017-2027)
1.5.1 Global Biosimilars and Follow-on Biologic Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Biosimilars and Follow-on Biologic Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biosimilars and Follow-on Biologic Market
2 INDUSTRY OUTLOOK
2.1 Biosimilars and Follow-on Biologic Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Biosimilars and Follow-on Biologic Market Drivers Analysis
2.4 Biosimilars and Follow-on Biologic Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biosimilars and Follow-on Biologic Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Biosimilars and Follow-on Biologic Industry Development
3 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET LANDSCAPE BY PLAYER
3.1 Global Biosimilars and Follow-on Biologic Sales Volume and Share by Player (2017-2022)
3.2 Global Biosimilars and Follow-on Biologic Revenue and Market Share by Player (2017-2022)
3.3 Global Biosimilars and Follow-on Biologic Average Price by Player (2017-2022)
3.4 Global Biosimilars and Follow-on Biologic Gross Margin by Player (2017-2022)
3.5 Biosimilars and Follow-on Biologic Market Competitive Situation and Trends
3.5.1 Biosimilars and Follow-on Biologic Market Concentration Rate
3.5.2 Biosimilars and Follow-on Biologic Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Biosimilars and Follow-on Biologic Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biosimilars and Follow-on Biologic Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Biosimilars and Follow-on Biologic Market Under COVID-19
4.5 Europe Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Biosimilars and Follow-on Biologic Market Under COVID-19
4.6 China Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Biosimilars and Follow-on Biologic Market Under COVID-19
4.7 Japan Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Biosimilars and Follow-on Biologic Market Under COVID-19
4.8 India Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Biosimilars and Follow-on Biologic Market Under COVID-19
4.9 Southeast Asia Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Biosimilars and Follow-on Biologic Market Under COVID-19
4.10 Latin America Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Biosimilars and Follow-on Biologic Market Under COVID-19
4.11 Middle East and Africa Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Biosimilars and Follow-on Biologic Market Under COVID-19
5 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Biosimilars and Follow-on Biologic Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biosimilars and Follow-on Biologic Revenue and Market Share by Type (2017-2022)
5.3 Global Biosimilars and Follow-on Biologic Price by Type (2017-2022)
5.4 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Human Growth Hormone (2017-2022)
5.4.2 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Erythropoietin (2017-2022)
5.4.3 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
5.4.4 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Insulin (2017-2022)
5.4.5 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Interferon (2017-2022)
5.4.6 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
5.4.7 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET ANALYSIS BY APPLICATION
6.1 Global Biosimilars and Follow-on Biologic Consumption and Market Share by Application (2017-2022)
6.2 Global Biosimilars and Follow-on Biologic Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Blood Disorders (2017-2022)
6.3.2 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Oncology Diseases (2017-2022)
6.3.3 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Chronic & Autoimmune Diseases (2017-2022)
6.3.4 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Growth Hormone Deficiencies (2017-2022)
6.3.5 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET FORECAST (2022-2027)
7.1 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Biosimilars and Follow-on Biologic Price and Trend Forecast (2022-2027)
7.2 Global Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Human Growth Hormone (2022-2027)
7.3.2 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Erythropoietin (2022-2027)
7.3.3 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
7.3.4 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Insulin (2022-2027)
7.3.5 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Interferon (2022-2027)
7.3.6 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
7.3.7 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Others (2022-2027)
7.4 Global Biosimilars and Follow-on Biologic Consumption Forecast by Application (2022-2027)
7.4.1 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Blood Disorders(2022-2027)
7.4.2 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Oncology Diseases(2022-2027)
7.4.3 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Chronic & Autoimmune Diseases(2022-2027)
7.4.4 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Growth Hormone Deficiencies(2022-2027)
7.4.5 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Others(2022-2027)
7.5 Biosimilars and Follow-on Biologic Market Forecast Under COVID-19
8 BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Biosimilars and Follow-on Biologic Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biosimilars and Follow-on Biologic Analysis
8.6 Major Downstream Buyers of Biosimilars and Follow-on Biologic Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biosimilars and Follow-on Biologic Industry
9 PLAYERS PROFILES
9.1 Mitsubishi Tanabe Pharma Corporation
9.1.1 Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.1.3 Mitsubishi Tanabe Pharma Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.2.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 CCL Pharmaceuticals
9.3.1 CCL Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.3.3 CCL Pharmaceuticals Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Amphastar Pharmaceuticals
9.4.1 Amphastar Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.4.3 Amphastar Pharmaceuticals Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biogen Idec
9.5.1 Biogen Idec Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.5.3 Biogen Idec Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Abbott
9.6.1 Abbott Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.6.3 Abbott Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 3SBio
9.7.1 3SBio Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.7.3 3SBio Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Abraxis BioScience
9.8.1 Abraxis BioScience Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.8.3 Abraxis BioScience Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Zenotech
9.9.1 Zenotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.9.3 Zenotech Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 GlaxoSmithKline (GSK)
9.10.1 GlaxoSmithKline (GSK) Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.10.3 GlaxoSmithKline (GSK) Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Sandoz
9.11.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.11.3 Sandoz Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Johnson & Johnson
9.12.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.12.3 Johnson & Johnson Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Alexion Pharmaceuticals,
9.13.1 Alexion Pharmaceuticals, Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.13.3 Alexion Pharmaceuticals, Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Ranbaxy Laboratories
9.14.1 Ranbaxy Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.14.3 Ranbaxy Laboratories Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Genentech
9.15.1 Genentech Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.15.3 Genentech Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Dr. Reddy’s Laboratories
9.16.1 Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.16.3 Dr. Reddy’s Laboratories Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Biosimilars and Follow-on Biologic Market
1.2 Biosimilars and Follow-on Biologic Market Segment by Type
1.2.1 Global Biosimilars and Follow-on Biologic Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biosimilars and Follow-on Biologic Market Segment by Application
1.3.1 Biosimilars and Follow-on Biologic Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biosimilars and Follow-on Biologic Market, Region Wise (2017-2027)
1.4.1 Global Biosimilars and Follow-on Biologic Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.3 Europe Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.4 China Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.5 Japan Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.6 India Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.8 Latin America Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Biosimilars and Follow-on Biologic Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biosimilars and Follow-on Biologic (2017-2027)
1.5.1 Global Biosimilars and Follow-on Biologic Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Biosimilars and Follow-on Biologic Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biosimilars and Follow-on Biologic Market
2 INDUSTRY OUTLOOK
2.1 Biosimilars and Follow-on Biologic Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Biosimilars and Follow-on Biologic Market Drivers Analysis
2.4 Biosimilars and Follow-on Biologic Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biosimilars and Follow-on Biologic Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Biosimilars and Follow-on Biologic Industry Development
3 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET LANDSCAPE BY PLAYER
3.1 Global Biosimilars and Follow-on Biologic Sales Volume and Share by Player (2017-2022)
3.2 Global Biosimilars and Follow-on Biologic Revenue and Market Share by Player (2017-2022)
3.3 Global Biosimilars and Follow-on Biologic Average Price by Player (2017-2022)
3.4 Global Biosimilars and Follow-on Biologic Gross Margin by Player (2017-2022)
3.5 Biosimilars and Follow-on Biologic Market Competitive Situation and Trends
3.5.1 Biosimilars and Follow-on Biologic Market Concentration Rate
3.5.2 Biosimilars and Follow-on Biologic Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Biosimilars and Follow-on Biologic Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biosimilars and Follow-on Biologic Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Biosimilars and Follow-on Biologic Market Under COVID-19
4.5 Europe Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Biosimilars and Follow-on Biologic Market Under COVID-19
4.6 China Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Biosimilars and Follow-on Biologic Market Under COVID-19
4.7 Japan Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Biosimilars and Follow-on Biologic Market Under COVID-19
4.8 India Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Biosimilars and Follow-on Biologic Market Under COVID-19
4.9 Southeast Asia Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Biosimilars and Follow-on Biologic Market Under COVID-19
4.10 Latin America Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Biosimilars and Follow-on Biologic Market Under COVID-19
4.11 Middle East and Africa Biosimilars and Follow-on Biologic Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Biosimilars and Follow-on Biologic Market Under COVID-19
5 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Biosimilars and Follow-on Biologic Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biosimilars and Follow-on Biologic Revenue and Market Share by Type (2017-2022)
5.3 Global Biosimilars and Follow-on Biologic Price by Type (2017-2022)
5.4 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Human Growth Hormone (2017-2022)
5.4.2 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Erythropoietin (2017-2022)
5.4.3 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
5.4.4 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Insulin (2017-2022)
5.4.5 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Interferon (2017-2022)
5.4.6 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
5.4.7 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET ANALYSIS BY APPLICATION
6.1 Global Biosimilars and Follow-on Biologic Consumption and Market Share by Application (2017-2022)
6.2 Global Biosimilars and Follow-on Biologic Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Blood Disorders (2017-2022)
6.3.2 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Oncology Diseases (2017-2022)
6.3.3 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Chronic & Autoimmune Diseases (2017-2022)
6.3.4 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Growth Hormone Deficiencies (2017-2022)
6.3.5 Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET FORECAST (2022-2027)
7.1 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Biosimilars and Follow-on Biologic Price and Trend Forecast (2022-2027)
7.2 Global Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Biosimilars and Follow-on Biologic Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biosimilars and Follow-on Biologic Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Human Growth Hormone (2022-2027)
7.3.2 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Erythropoietin (2022-2027)
7.3.3 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
7.3.4 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Insulin (2022-2027)
7.3.5 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Interferon (2022-2027)
7.3.6 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
7.3.7 Global Biosimilars and Follow-on Biologic Revenue and Growth Rate of Others (2022-2027)
7.4 Global Biosimilars and Follow-on Biologic Consumption Forecast by Application (2022-2027)
7.4.1 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Blood Disorders(2022-2027)
7.4.2 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Oncology Diseases(2022-2027)
7.4.3 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Chronic & Autoimmune Diseases(2022-2027)
7.4.4 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Growth Hormone Deficiencies(2022-2027)
7.4.5 Global Biosimilars and Follow-on Biologic Consumption Value and Growth Rate of Others(2022-2027)
7.5 Biosimilars and Follow-on Biologic Market Forecast Under COVID-19
8 BIOSIMILARS AND FOLLOW-ON BIOLOGIC MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Biosimilars and Follow-on Biologic Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biosimilars and Follow-on Biologic Analysis
8.6 Major Downstream Buyers of Biosimilars and Follow-on Biologic Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biosimilars and Follow-on Biologic Industry
9 PLAYERS PROFILES
9.1 Mitsubishi Tanabe Pharma Corporation
9.1.1 Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.1.3 Mitsubishi Tanabe Pharma Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.2.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 CCL Pharmaceuticals
9.3.1 CCL Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.3.3 CCL Pharmaceuticals Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Amphastar Pharmaceuticals
9.4.1 Amphastar Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.4.3 Amphastar Pharmaceuticals Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biogen Idec
9.5.1 Biogen Idec Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.5.3 Biogen Idec Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Abbott
9.6.1 Abbott Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.6.3 Abbott Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 3SBio
9.7.1 3SBio Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.7.3 3SBio Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Abraxis BioScience
9.8.1 Abraxis BioScience Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.8.3 Abraxis BioScience Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Zenotech
9.9.1 Zenotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.9.3 Zenotech Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 GlaxoSmithKline (GSK)
9.10.1 GlaxoSmithKline (GSK) Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.10.3 GlaxoSmithKline (GSK) Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Sandoz
9.11.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.11.3 Sandoz Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Johnson & Johnson
9.12.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.12.3 Johnson & Johnson Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Alexion Pharmaceuticals,
9.13.1 Alexion Pharmaceuticals, Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.13.3 Alexion Pharmaceuticals, Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Ranbaxy Laboratories
9.14.1 Ranbaxy Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.14.3 Ranbaxy Laboratories Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Genentech
9.15.1 Genentech Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.15.3 Genentech Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Dr. Reddy’s Laboratories
9.16.1 Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Biosimilars and Follow-on Biologic Product Profiles, Application and Specification
9.16.3 Dr. Reddy’s Laboratories Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Biosimilars and Follow-on Biologic Product Picture
Table Global Biosimilars and Follow-on Biologic Market Sales Volume and CAGR (%) Comparison by Type
Table Biosimilars and Follow-on Biologic Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Biosimilars and Follow-on Biologic Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Biosimilars and Follow-on Biologic Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biosimilars and Follow-on Biologic Industry Development
Table Global Biosimilars and Follow-on Biologic Sales Volume by Player (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume Share by Player (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Share by Player in 2021
Table Biosimilars and Follow-on Biologic Revenue (Million USD) by Player (2017-2022)
Table Biosimilars and Follow-on Biologic Revenue Market Share by Player (2017-2022)
Table Biosimilars and Follow-on Biologic Price by Player (2017-2022)
Table Biosimilars and Follow-on Biologic Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars and Follow-on Biologic Sales Volume, Region Wise (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Market Share, Region Wise in 2021
Table Global Biosimilars and Follow-on Biologic Revenue (Million USD), Region Wise (2017-2022)
Table Global Biosimilars and Follow-on Biologic Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue Market Share, Region Wise in 2021
Table Global Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume by Type (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume Market Share by Type (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Market Share by Type in 2021
Table Global Biosimilars and Follow-on Biologic Revenue (Million USD) by Type (2017-2022)
Table Global Biosimilars and Follow-on Biologic Revenue Market Share by Type (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue Market Share by Type in 2021
Table Biosimilars and Follow-on Biologic Price by Type (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Human Growth Hormone (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Human Growth Hormone (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Interferon (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Interferon (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption Market Share by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption Revenue Market Share by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Blood Disorders (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Oncology Diseases (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Chronic & Autoimmune Diseases (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Growth Hormone Deficiencies (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Others (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Price and Trend Forecast (2022-2027)
Figure USA Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Biosimilars and Follow-on Biologic Market Sales Volume Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Sales Volume Market Share Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Market Revenue (Million USD) Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Revenue Market Share Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Price Forecast, by Type
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Human Growth Hormone (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Human Growth Hormone (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Interferon (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Interferon (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Biosimilars and Follow-on Biologic Market Consumption Forecast, by Application
Table Global Biosimilars and Follow-on Biologic Consumption Market Share Forecast, by Application
Table Global Biosimilars and Follow-on Biologic Market Revenue (Million USD) Forecast, by Application
Table Global Biosimilars and Follow-on Biologic Revenue Market Share Forecast, by Application
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Blood Disorders (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Oncology Diseases (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Chronic & Autoimmune Diseases (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Growth Hormone Deficiencies (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Biosimilars and Follow-on Biologic Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitsubishi Tanabe Pharma Corporation Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table CCL Pharmaceuticals Profile
Table CCL Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CCL Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure CCL Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Amphastar Pharmaceuticals Profile
Table Amphastar Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amphastar Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Amphastar Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Biogen Idec Profile
Table Biogen Idec Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Idec Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Biogen Idec Revenue (Million USD) Market Share 2017-2022
Table Abbott Profile
Table Abbott Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Abbott Revenue (Million USD) Market Share 2017-2022
Table 3SBio Profile
Table 3SBio Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure 3SBio Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure 3SBio Revenue (Million USD) Market Share 2017-2022
Table Abraxis BioScience Profile
Table Abraxis BioScience Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abraxis BioScience Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Abraxis BioScience Revenue (Million USD) Market Share 2017-2022
Table Zenotech Profile
Table Zenotech Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zenotech Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Zenotech Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline (GSK) Profile
Table GlaxoSmithKline (GSK) Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline (GSK) Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure GlaxoSmithKline (GSK) Revenue (Million USD) Market Share 2017-2022
Table Sandoz Profile
Table Sandoz Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Alexion Pharmaceuticals, Profile
Table Alexion Ph
Figure Biosimilars and Follow-on Biologic Product Picture
Table Global Biosimilars and Follow-on Biologic Market Sales Volume and CAGR (%) Comparison by Type
Table Biosimilars and Follow-on Biologic Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Biosimilars and Follow-on Biologic Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Biosimilars and Follow-on Biologic Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biosimilars and Follow-on Biologic Industry Development
Table Global Biosimilars and Follow-on Biologic Sales Volume by Player (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume Share by Player (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Share by Player in 2021
Table Biosimilars and Follow-on Biologic Revenue (Million USD) by Player (2017-2022)
Table Biosimilars and Follow-on Biologic Revenue Market Share by Player (2017-2022)
Table Biosimilars and Follow-on Biologic Price by Player (2017-2022)
Table Biosimilars and Follow-on Biologic Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars and Follow-on Biologic Sales Volume, Region Wise (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Market Share, Region Wise in 2021
Table Global Biosimilars and Follow-on Biologic Revenue (Million USD), Region Wise (2017-2022)
Table Global Biosimilars and Follow-on Biologic Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue Market Share, Region Wise in 2021
Table Global Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume by Type (2017-2022)
Table Global Biosimilars and Follow-on Biologic Sales Volume Market Share by Type (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume Market Share by Type in 2021
Table Global Biosimilars and Follow-on Biologic Revenue (Million USD) by Type (2017-2022)
Table Global Biosimilars and Follow-on Biologic Revenue Market Share by Type (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue Market Share by Type in 2021
Table Biosimilars and Follow-on Biologic Price by Type (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Human Growth Hormone (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Human Growth Hormone (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Interferon (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Interferon (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption Market Share by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption Revenue Market Share by Application (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Blood Disorders (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Oncology Diseases (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Chronic & Autoimmune Diseases (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Growth Hormone Deficiencies (2017-2022)
Table Global Biosimilars and Follow-on Biologic Consumption and Growth Rate of Others (2017-2022)
Figure Global Biosimilars and Follow-on Biologic Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Price and Trend Forecast (2022-2027)
Figure USA Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biosimilars and Follow-on Biologic Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biosimilars and Follow-on Biologic Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Biosimilars and Follow-on Biologic Market Sales Volume Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Sales Volume Market Share Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Market Revenue (Million USD) Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Revenue Market Share Forecast, by Type
Table Global Biosimilars and Follow-on Biologic Price Forecast, by Type
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Human Growth Hormone (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Human Growth Hormone (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Interferon (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Interferon (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Biosimilars and Follow-on Biologic Market Consumption Forecast, by Application
Table Global Biosimilars and Follow-on Biologic Consumption Market Share Forecast, by Application
Table Global Biosimilars and Follow-on Biologic Market Revenue (Million USD) Forecast, by Application
Table Global Biosimilars and Follow-on Biologic Revenue Market Share Forecast, by Application
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Blood Disorders (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Oncology Diseases (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Chronic & Autoimmune Diseases (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Growth Hormone Deficiencies (2022-2027)
Figure Global Biosimilars and Follow-on Biologic Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Biosimilars and Follow-on Biologic Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Mitsubishi Tanabe Pharma Corporation Profile
Table Mitsubishi Tanabe Pharma Corporation Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitsubishi Tanabe Pharma Corporation Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table CCL Pharmaceuticals Profile
Table CCL Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CCL Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure CCL Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Amphastar Pharmaceuticals Profile
Table Amphastar Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amphastar Pharmaceuticals Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Amphastar Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Biogen Idec Profile
Table Biogen Idec Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Idec Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Biogen Idec Revenue (Million USD) Market Share 2017-2022
Table Abbott Profile
Table Abbott Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Abbott Revenue (Million USD) Market Share 2017-2022
Table 3SBio Profile
Table 3SBio Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure 3SBio Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure 3SBio Revenue (Million USD) Market Share 2017-2022
Table Abraxis BioScience Profile
Table Abraxis BioScience Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abraxis BioScience Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Abraxis BioScience Revenue (Million USD) Market Share 2017-2022
Table Zenotech Profile
Table Zenotech Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zenotech Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Zenotech Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline (GSK) Profile
Table GlaxoSmithKline (GSK) Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline (GSK) Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure GlaxoSmithKline (GSK) Revenue (Million USD) Market Share 2017-2022
Table Sandoz Profile
Table Sandoz Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Biosimilars and Follow-on Biologic Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Biosimilars and Follow-on Biologic Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Alexion Pharmaceuticals, Profile
Table Alexion Ph
